Literature DB >> 6185566

Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies.

J White, K M Haskins, P Marrack, J Kappler.   

Abstract

Murine T cell hybridomas bearing receptors for antigen plus I region gene products were used as immunogens in mice in an effort to raise anti-receptor antisera. The antisera were assayed for anti-receptor activity by the ability to inhibit interleukin 2 production by the T cell hybridomas stimulated by antigen and I region expressing antigen-presenting cells. The T cell hybridomas used in these experiments were made by fusing antigen-specific, I region-restricted BALB/c T cell blasts to the AKR thymoma, BW5147. Three groups of mice were immunized with the T cell hybridomas: (BALB/c X AKR)F1 animals, syngeneic to the hybridoma; (BALB.B X aKR)F1 animals, differing from the hybridomas at H2; and (C.B20 X AKR)F1 animals, differing from the hybridomas at Igh. Mice were immunized multiple times and sera from individual animals were assayed for anti-receptor antibodies. In all groups, some mice produced anti-receptor antibodies by the criterion that they were inhibitory in the assay mentioned above. The frequency of mice producing these inhibitory antibodies varied considerably between groups, with the (BALB.B X AKR)F1 animals producing these antibodies most frequently, and the (BALB/c X AKR)F1 animals producing them least often. All inhibitory antisera were idiotypically specific; they inhibited the response of the immunizing T cell hybridomas, but not the responses of closely related hybridomas with different specificities. Moreover, when they could be absorbed, the inhibitory antibodies could only be absorbed by the immunizing hybridoma. It is hoped that these antisera, and B cell hybridomas prepared from the immunized animals, will be useful in the elucidation of the structure of the receptors for antigen plus I region products on T cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6185566

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  Serum proteases alter the antigenicity of peptides presented by class I major histocompatibility complex molecules.

Authors:  L D Falo; L J Colarusso; B Benacerraf; K L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

2.  Reassociation with beta 2-microglobulin is necessary for Kb class I major histocompatibility complex binding of exogenous peptides.

Authors:  K L Rock; L E Rothstein; S R Gamble; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

3.  Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins.

Authors:  K P Kearse; G W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

Review 4.  Modular design of immunological synapses and kinapses.

Authors:  Michael L Dustin
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-07       Impact factor: 10.005

5.  Evidence for a functional receptor for cyclosporin A on the surface of lymphocytes.

Authors:  N A Cacalano; B X Chen; W L Cleveland; B F Erlanger
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

6.  T cell chemotaxis to lysophosphatidylcholine through the G2A receptor.

Authors:  Caius G Radu; Li V Yang; Mireille Riedinger; Matthew Au; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-17       Impact factor: 11.205

7.  Monoclonal antibodies specific for a murine cytotoxic T-lymphocyte clone.

Authors:  U D Staerz; M S Pasternack; J R Klein; J D Benedetto; M J Bevan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

8.  A method for production of antibodies to human T-cell receptor beta-chain variable regions.

Authors:  Y W Choi; B Kotzin; J Lafferty; J White; M Pigeon; R Kubo; J Kappler; P Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

9.  Cellular and peptide requirements for in vitro clonal deletion of immature thymocytes.

Authors:  K Iwabuchi; K Nakayama; R L McCoy; F Wang; T Nishimura; S Habu; K M Murphy; D Y Loh
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

10.  T cell clones and their products: experimental clues for the immunoprophylaxis and immunotherapy of intracellular bacterial infections?

Authors:  S H Kaufmann
Journal:  Infection       Date:  1985       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.